KENNEWICK, Wash., Aug. 22, 2007 (PRIME NEWSWIRE) -- Advanced Medical Isotopes Corporation (AMIC) (Pink Sheets:ADMD) of Kennewick announced today that it has contracted with the Department of Energy's Pacific Northwest National Laboratory to conduct medical isotope production calculations.
"As advanced concepts for low-cost, compact electronic systems for isotope production are developed," said AMIC Chief Scientific Officer, Dr. Robert E. Schenter, "it will be important to calculate and evaluate the relative production efficiencies and costs of both larger and smaller systems to optimize isotope production."
AMIC will provide isotope production calculations for a broad spectrum of potential source and target configurations for both nuclear reactors and charged-particle accelerators. The 13-month contract will commence in September.
About AMIC
Advanced Medical Isotopes Corporation is engaged in the development of advanced production systems and processes for bringing previously unavailable medical isotopes to the marketplace and advancing systems for local product production. The field of nuclear medicine has routinely utilized radioisotopes in the diagnosis of disease while new processes are being pioneered for the targeted treatment of diseases such as cancer in preference to surgical techniques. Advanced Medical Isotopes Corporation products support the accessibility to these less invasive therapeutic processes by advancing systems for lower cost production and improving supply availability of medical isotopes to hospitals and clinical treatment centers. For more information, please visit http://www.isotopia.us
Forward-Looking Statements
Except for historical information contained herein, the matters set forth in this press release, such as statements relating to the company's ability to drive technological developments and the acceptance and timing of product introductions, are forward-looking statements that are subject to risks and uncertainties, including but not limited to, timely development and acceptance of new products, the impact of competitive products and pricing, the timely development and release of products by suppliers, and other risks.